Aspergillosis

IDSA Aspergillosis

IDSA Aspergillosis GUIDELINES App brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/102840

Contents of this Issue

Navigation

Page 3 of 9

Diagnosis Diagnosis of Invasive Aspergillosis Determine site of infection by signs, symptoms, radiography, host factors Establish proven or probable IA (see Key Points for definitions) Proven/Probable Culture confirmation; requires recovery of organism from normally sterile site Alternative Testing to Establish a Probable Diagnosis Satisfy criteria for probable IA with surrogate nonculture-based diagnosis: • Positive galactomannan EIA1 or • Positive beta-glucan assay + radiologically compatible CT scan2 in immunocompromised host with clinical findings of infections Standard Diagnostic Procedures3 • Bronchoalveolar lavage (BAL) • Transthoracic percutaneous needle aspirate • Video-assisted thoracoscopic biopsy • Cultures of material obtained plated on fungal media for growth of Aspergillus spp For Patients Unable to Undergo Invasive Testing Use nonculture-based surrogate markers as in alternative testing to establish a probable diagnosis This enzyme immunoassay (EIA) demonstrates good sensitivity for detection of IA in patients with  hematological malignancy, but is less sensitive in non-neutropenic patients. 2 Recognition of "halo sign" and "air-crescent" by CT scan facilitates diagnosis of IA in  immunocompromised hematology patients–these radiologic features are characteristic, but are not  diagnostic of IA. 3 May produce false negatives where procedures cannot be performed directly in affected area. Testing BAL  fluid for galactomannan may increase yield of positive results. 1

Articles in this issue

Archives of this issue

view archives of Aspergillosis - IDSA Aspergillosis